OpenNashEarnings

Health Care · NYSE: HCA

HCA Healthcare earnings: results, call transcripts & KPI history

2 quarters · fiscal year ends December · next results expected around 26 Jan 2027

Investor relations ↗SEC filings ↗KPIs as CSV

Latest: Q3 2026

HCA grew volumes for a 22nd straight quarter on emergency, neonatal and ambulatory demand, even as lost exchange coverage pushed more patients into uninsured status.

HCA's patient volumes kept growing, led by emergency room visits, neonatal, cardiac and trauma care, while elective surgery stayed weak. Many patients who lost health insurance exchange coverage became uninsured almost one-for-one, and uninsured patients reached about 10.5 % of equivalent admissions. Insured demand grew faster than in the first half of the year. Hospitals are running at record occupancy, and management is adding beds and expanding its outpatient network.

Read the Q3 2026 summary →

Quarters

KPI history

Revenue$19.8B+3.6% y/yQ3 2026
Q4 2024: $18.3B (worked out from the annual figure)Q4 ’24$18.3BQ1 2025: $18.3BQ1 ’25$18.3BQ2 2025: $18.6BQ2 ’25$18.6BQ3 2025: $19.2BQ3 ’25$19.2BQ4 2025: $19.5B (worked out from the annual figure)Q4 ’25$19.5BQ1 2026: $19.1BQ1 ’26$19.1BQ2 2026: $20.2BQ2 ’26$20.2BQ3 2026: $19.8BQ3 ’26$19.8B

Fourth quarter worked out from the annual figure.

Data
Q4 2024$18.3B *
Q1 2025$18.3B
Q2 2025$18.6B
Q3 2025$19.2B
Q4 2025$19.5B *
Q1 2026$19.1B
Q2 2026$20.2B
Q3 2026$19.8B
Diluted EPS (GAAP)$7.27+4.5% y/yQ3 2026
Q1 2025: $6.45Q1 ’25$6.45Q2 2025: $6.83Q2 ’25$6.83Q3 2025: $6.96Q3 ’25$6.96Q1 2026: $7.15Q1 ’26$7.15Q2 2026: $7.62Q2 ’26$7.62Q3 2026: $7.27Q3 ’26$7.27
Data
Q1 2025$6.45
Q2 2025$6.83
Q3 2025$6.96
Q1 2026$7.15
Q2 2026$7.62
Q3 2026$7.27

Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.

Free cash flow$3.1B−0.8% y/yQ3 2026
Q4 2024: $1.3BQ4 ’24$1.3BQ1 2025: $660.0MQ1 ’25$660.0MQ2 2025: $3.0BQ2 ’25$3.0BQ3 2025: $3.1BQ3 ’25$3.1BQ4 2025: $870.0MQ4 ’25$870.0MQ1 2026: $895.0MQ1 ’26$895.0MQ2 2026: $1.1BQ2 ’26$1.1BQ3 2026: $3.1BQ3 ’26$3.1B
Data
Q4 2024$1.3B
Q1 2025$660.0M
Q2 2025$3.0B
Q3 2025$3.1B
Q4 2025$870.0M
Q1 2026$895.0M
Q2 2026$1.1B
Q3 2026$3.1B

Operating cash flow minus capital expenditure, from cash flow statements.

Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Revenue$18.3Bd$18.3B$18.6B$19.2B$19.5Bd$19.1B$20.2B$19.8B
Net income$1.4Bd$1.6B$1.7B$1.6B$1.9Bd$1.6B$1.7B$1.6B
Diluted EPS—$6.45$6.83$6.96—$7.15$7.62$7.27
Operating cash flow$2.6Bd$1.7B$4.2Bd$4.4Bd$2.4Bd$2.0B$2.3Bd$4.5Bd
Capital expenditure$1.3Bd$991.0M$1.2Bd$1.3Bd$1.5Bd$1.1B$1.2Bd$1.4Bd
Free cash flow$1.3B$660.0M$3.0B$3.1B$870.0M$895.0M$1.1B$3.1B

From XBRL data in 10-Q and 10-K filings. d derived: a fourth quarter is the full year minus the first nine months, and cash flows are year-to-date figures differenced.

10-K and 10-Q filings